Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)
Clinical trial NCT05687279 · COMPLETED
Trial details
- NCT number
- NCT05687279
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2024-12-27
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.